Analytical testing, QC

Biolog adds contract microbial service capabilities through MIDI Labs buyout

10-Jan-2023 By Nick Taylor

Biolog has acquired the contract laboratory MIDI Labs to add microbial identification and enumeration services to its offering.

Phlow and US Pharmacopeia open labs for API R&D services

03-Jan-2023 By Ben Hargreaves

The partners announce that their lab facilities have opened, equipped with advanced manufacturing technologies to create API and KSMs.

Millstone strikes back-to-back takeovers to create new testing services division

15-Dec-2022 By Nick Taylor

Millstone Medical Outsourcing is keeping up the pace of its deal-driven expansion strategy by closing the takeover of regulatory testing services provider Ethide Laboratories.

Altasciences expands Missouri bioanalytical site to support preclinical and clinical studies

01-Nov-2022 By Nick Taylor

Altasciences is expanding its facility in Columbia, Missouri to provide bioanalytical services in support of preclinical and clinical studies conducted in the US.

Thermo Fisher continues to expand clinical research capacity with $59m lab expansion

31-Oct-2022 By Maggie Lynch

Thermo Fisher’s clinical research subsidiary, PPD, invests $59 million in sample management and testing capacity for vaccines and cell and gene therapy products with its expansion of laboratory operations in Kentucky.

CPHI Pharma Award finalists announced

26-Oct-2022

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

Industry body points to ‘clear and serious threat’ to clinical research in UK

26-Oct-2022 By Ben Hargreaves

The ABPI releases a report that shows the number of clinical trials taking place in the UK fell by a large amount between the years 2017 and 2021.

PathoQuest opens US facility to provide NGS biosafety testing services

25-Oct-2022 By Nick Taylor

PathoQuest has opened a facility in Pennsylvania to provide next-generation sequencing (NGS) testing services to the biopharma industry.

Thermo Fisher adds clinical research lab as part of $97m expansion

24-Oct-2022 By Ben Hargreaves

The company opens a bioanalytical lab in the US, which offers an additional 59,000-square-feet of space to the overall facility, making it “one of the largest laboratories of its kind.”

Clinisys formed to help companies manage ‘revolution’ of lab science

12-Oct-2022 By Ben Hargreaves

Clinisys emerges after the combination of three companies, Sunquest Information Systems, Horizon Lab Systems, and Apollo Lims.

Gilead takes legal fight to ‘kingpins’ of counterfeit HIV medicine

04-Oct-2022 By Ben Hargreaves

The company announces further measures against a counterfeiting network it accused of being responsible for selling illegitimate Gilead HIV medications.

Thermo Fisher hails PPD’s wins of ‘very large’ customers following merger

20-Sep-2022 By Nick Taylor

Thermo Fisher Scientific’s clinical service unit PPD has won some “very large” customers since becoming part of the broader group in a mega-merger, according to CEO Marc Casper.

Science 37 taps NuvoAir to enable remote collection of lung health endpoints

20-Sep-2022 By Nick Taylor

Science 37 has partnered with NuvoAir to incorporate connected devices for the remote collection of respiratory endpoints data into clinical trial designs.

Exagen on why AVISE test can end the ‘diagnostic odyssey’

19-Sep-2022

Autoimmune diagnostics life sciences company Exagen is heralding the completion of the CAPSTONE study as evidence that its AVISE Lupus test is more clinically effective than traditional ANA methods (tANA), benefiting patients, providers and payers by...

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Blending human knowhow, artificial intelligence aids drug discovery

02-Aug-2022 By Jenni Spinner

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics.

On-demand cleanrooms help pharma manufacturers ‘fail fast’

13-Jul-2022 By Jenni Spinner

A representative from life-science services company Azzur Group explains how flexibility and speed can help in reaching the best solution more efficiently.

Lymphoma Research Foundation awards $5.7m to pursue blood cancer treatments

12-Jul-2022 By Jenni Spinner

The organization has given 29 research grants to scientists representing 17 different US institutions pursuing lymphoma treatments and cures in their work.

FDA outlines benefit-risk approach to drug or biologic product quality assessment

10-May-2022 By Jane Byrne

The US FDA released new draft guidance yesterday discussing, among other challenges, how unresolved product quality issues might be addressed in the context of regulatory decision-making.

The right tech can fill gap between lab scientist and data: ACD/Labs

16-Mar-2022 By Jenni Spinner

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

Stanford laboratory aligns with Pepper Bio to target tough cancers

03-Mar-2022 By Jenni Spinner

The drug discovery firm will work with the Dean Felsher Laboratory, using the company’s transomics platform to discover therapies for untreatable cancers.

Managing QC lab data is important part of research equation: Veeva

13-Jan-2022 By Jenni Spinner

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.

AI-based blood analysis tool geared toward decentralized diagnostics

01-Dec-2021 By Jenni Spinner

With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.

AstraZeneca opens new advanced therapeutics R&D facility in Cambridge

23-Nov-2021 By Jane Byrne

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

Pharmaceutical packaging firm adds QC laboratory in Ireland

10-Nov-2021 By Jenni Spinner

Wasdell, a UK-based packaging and manufacturing provider in the UK, has opened a quality control laboratory in Dundalk to analyze products for its pharmaceutical clientele.

AAPS PharmSci 360

PharmSci 360 invites industry pros to ‘rethink and evolve’

14-Oct-2021 By Jenni Spinner

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

Tech Innovations: September 2021

16-Sep-2021 By Jenni Spinner

This month’s roundup of new technology, equipment, and industry partnerships includes news from IBM, IQVIA, Mediata, Labcorp, and other notable companies.

Cloud lab solution empowers access of research tech from miles away

26-Aug-2021 By Jenni Spinner

Emerald Cloud Lab’s remote, automated laboratory technology puts pieces of advanced scientific equipment within the reach of smaller research outfits.

Wave of acquisitions hits pharma industry this week

15-Jul-2021 By Jenni Spinner

The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.

Cryo-EM advancements lead to ‘resolution revolution’: Thermo Fisher

22-Jun-2021 By Jenni Spinner

An academic researcher and and company expert discuss on how evolving cryogenic electron microscopy has led to high resolutions and accelerated results.

Azzur opens new on-demand cleanroom facility in California

03-Jun-2021 By Jenni Spinner

The company’s Azzur Cleanrooms on Demand division has established another facility in Vista, a city in the San Diego Area, for life-sciences operations.

Lonza leader outlines small-molecule trends for 2021 and beyond

06-May-2021 By Jenni Spinner

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

Latest FDA COVID-19-related advice and actions

04-May-2021 By Jenni Spinner

The US agency continues to keep a watchful eye over the nation’s pandemic response, issuing advice to professionals and taking action where appropriate.

PRA expands COVID-19 pharmacovigilance resources

04-May-2021 By Jenni Spinner

The CRO is offering an expanded range of post-authorization solutions designed to help developers with treatments and vaccines in their product pipeline

Study examines solution to gauge adverse drug event risk

26-Apr-2021 By Jenni Spinner

Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.

Cancer detection tech uses AI, whole-genome sequencing

22-Apr-2021 By Jenni Spinner

An advanced cancer detection platform from C2i Genomics (reportedly capable of spotting miniscule traces of the disease) recently landed $100m in funding.

COVID-19 highlights need for digital lab connectivity: Waters

22-Apr-2021 By Jenni Spinner

A leader from the laboratory solutions provider talks about how the virus has created challenges for researchers, and how those obstacles might be cleared.

Immunomics firm reels in $14m to advance drug discovery

20-Apr-2021 By Jenni Spinner

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

Novartis, Artios cancer discovery deal worth up to $1.3bn

12-Apr-2021 By Jenni Spinner

The collaboration centers on development of precision cancer treatments, through discovery and validation of next-generation DNA damage response targets.

IQVIA completes acquisition of Q2 Diagnostics

05-Apr-2021 By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

Vocal biomarkers enable unique diagnosis, monitoring capabilities

02-Mar-2021 By Jenni Spinner

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions.

On-demand capabilities help drug developers in a pinch

18-Feb-2021 By Jenni Spinner

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

Clinical data shows BD COVID-19 antigen test might offer an edge

11-Feb-2021 By Jenni Spinner

A peer-reviewed study indicates that the company’s antigen test could be more selective in detecting contagious COVID-19 patients than PCR testing.

CELLINK launches all-in-one imager, single-cell dispenser

09-Feb-2021 By Jenni Spinner

The UP.SIGHT single-sell dispensing system is designed to boost efficiency in cell-line development workflows and offer double assurance of clonality.

COVID-19 tools from Cerba aim to save researchers time

28-Jan-2021 By Jenni Spinner

The company has released two products designed to help clinical researchers accelerate development of treatments and vaccines for the COVID-19 virus.

Calyx spins off medical imaging, eClinical solutions firm

19-Jan-2021 By Jenni Spinner

Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.

Lonza scientific team on the hunt for pharma fakery

13-Jan-2021 By Jenni Spinner

The company’s Forensic Chemistry Group comprises a collection of technical professionals using their respective talents to detect and thwart counterfeiting.

PRA Health Sciences expands COVID-19 monitoring program

11-Jan-2021 By Jenni Spinner

The CRO is working with PWNHealth and Fulgent Genetics to enhance its monitoring program, including the addition of at-home COVID-19 testing capabilities.

First FDA COVID-19 update of 2021

04-Jan-2021 By Jenni Spinner

As healthcare providers and other high-priority patients begin receiving the vaccines, the agency continues to act to help the national pandemic response.

DNA analysis could pinpoint ‘long haulers’ among COVID-19 patients

23-Dec-2020 By Jenni Spinner

The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.